Aehr Current Ratio vs Price to Sales Ratio Analysis
AEHR Stock | USD 11.14 0.58 5.49% |
Aehr Test financial indicator trend analysis is way more than just evaluating Aehr Test Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aehr Test Systems is a good investment. Please check the relationship between Aehr Test Current Ratio and its Price To Sales Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Current Ratio vs Price To Sales Ratio
Current Ratio vs Price to Sales Ratio Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aehr Test Systems Current Ratio account and Price to Sales Ratio. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Aehr Test's Current Ratio and Price to Sales Ratio is 0.8. Overlapping area represents the amount of variation of Current Ratio that can explain the historical movement of Price to Sales Ratio in the same time period over historical financial statements of Aehr Test Systems, assuming nothing else is changed. The correlation between historical values of Aehr Test's Current Ratio and Price to Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Ratio of Aehr Test Systems are associated (or correlated) with its Price to Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price to Sales Ratio has no effect on the direction of Current Ratio i.e., Aehr Test's Current Ratio and Price to Sales Ratio go up and down completely randomly.
Correlation Coefficient | 0.8 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Price To Sales Ratio
Price to Sales Ratio is figured by comparing Aehr Test Systems stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Aehr Test sales, a figure that is much harder to manipulate than other Aehr Test Systems multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Most indicators from Aehr Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aehr Test Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. At this time, Aehr Test's Tax Provision is relatively stable compared to the past year. As of 04/24/2024, Enterprise Value Over EBITDA is likely to grow to 63.14, while Selling General Administrative is likely to drop slightly above 8.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 23.7M | 32.7M | 37.7M | 39.5M | Total Revenue | 50.8M | 65.0M | 74.7M | 78.4M |
Aehr Test fundamental ratios Correlations
Click cells to compare fundamentals
Aehr Test Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aehr Test fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.6M | 21.7M | 62.3M | 98.1M | 112.9M | 118.5M | |
Other Current Liab | 1.4M | 2.2M | 3.6M | 4.1M | 3.7M | 1.9M | |
Total Current Liabilities | 3.9M | 9.1M | 11.0M | 16.3M | 18.8M | 19.7M | |
Total Stockholder Equity | 14.1M | 11.4M | 51.0M | 75.6M | 68.0M | 71.4M | |
Property Plant And Equipment Net | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Debt | (1.5M) | 241K | (30.5M) | (23.8M) | (21.4M) | (20.3M) | |
Retained Earnings | (74.3M) | (76.3M) | (66.9M) | (52.3M) | (47.1M) | (49.4M) | |
Accounts Payable | 945K | 2.9M | 4.2M | 9.2M | 10.6M | 11.1M | |
Cash | 5.4M | 4.6M | 31.5M | 30.1M | 34.6M | 36.3M | |
Non Current Assets Total | 2.9M | 2.5M | 2.3M | 9.1M | 8.2M | 8.6M | |
Non Currrent Assets Other | 73K | 118K | 121K | 81K | 72.9K | 69.3K | |
Cash And Short Term Investments | 5.4M | 4.6M | 31.5M | 47.9M | 55.1M | 57.8M | |
Net Receivables | 3.7M | 5.2M | 12.9M | 16.6M | 19.1M | 20.0M | |
Common Stock Shares Outstanding | 22.9M | 23.5M | 27.8M | 29.2M | 33.6M | 35.3M | |
Liabilities And Stockholders Equity | 20.6M | 21.7M | 62.3M | 98.1M | 112.9M | 118.5M | |
Non Current Liabilities Total | 2.7M | 1.2M | 325K | 6.2M | 7.2M | 7.5M | |
Inventory | 8.0M | 8.8M | 15.1M | 23.9M | 27.5M | 28.9M | |
Other Current Assets | 512K | 551K | 613K | 621K | 558.9K | 861.9K | |
Other Stockholder Equity | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 154.3M | |
Total Liab | 6.5M | 10.2M | 11.3M | 22.5M | 25.9M | 27.2M | |
Property Plant And Equipment Gross | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Total Current Assets | 17.7M | 19.2M | 60.0M | 89.0M | 102.4M | 107.5M | |
Accumulated Other Comprehensive Income | 2.2M | (28K) | (105K) | (155K) | (178.3K) | (169.3K) | |
Current Deferred Revenue | 170K | 189K | 2.4M | 2.8M | 3.2M | 3.4M | |
Common Stock Total Equity | 221K | 227K | 231K | 237K | 272.6K | 286.2K | |
Common Stock | 231K | 237K | 271K | 285K | 327.8K | 344.1K | |
Other Liab | 22K | 148K | 113K | 72K | 64.8K | 61.6K | |
Other Assets | 153K | 198K | 201K | 231K | 207.9K | 380.5K | |
Property Plant Equipment | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Tangible Assets | 14.1M | 11.4M | 51.0M | 75.6M | 86.9M | 91.3M | |
Retained Earnings Total Equity | (66.2M) | (71.5M) | (74.3M) | (76.3M) | (68.7M) | (72.1M) | |
Capital Surpluse | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 85.6M | |
Deferred Long Term Liab | 522K | 342K | 22K | 99K | 113.9K | 173.1K |
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.Moving together with Aehr Stock
0.75 | MX | MagnaChip Semiconductor Financial Report 1st of May 2024 | PairCorr |
0.71 | ICG | Intchains Group Tech Boost | PairCorr |
0.77 | INTC | Intel Earnings Call Tomorrow | PairCorr |
Moving against Aehr Stock
0.82 | GDDY | Godaddy Financial Report 2nd of May 2024 | PairCorr |
0.43 | MSFT | Microsoft Earnings Call Tomorrow | PairCorr |
0.41 | SQ | Block Inc Aggressive Push | PairCorr |
The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Aehr Test Systems information on this page should be used as a complementary analysis to other Aehr Test's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Aehr Stock analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Aehr Test's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aehr Test. If investors know Aehr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aehr Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.538 | Earnings Share 0.52 | Revenue Per Share 2.506 | Quarterly Revenue Growth (0.56) | Return On Assets 0.0885 |
The market value of Aehr Test Systems is measured differently than its book value, which is the value of Aehr that is recorded on the company's balance sheet. Investors also form their own opinion of Aehr Test's value that differs from its market value or its book value, called intrinsic value, which is Aehr Test's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aehr Test's market value can be influenced by many factors that don't directly affect Aehr Test's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aehr Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aehr Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aehr Test's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.